A randomized prospective comparison of two FDA approved intravenous catheters in the
emergency department setting. The Terumo SurFlash Plus offers novel technologies that promise
to increase intravenous access success rates and decrease blood contamination of the
insertion site. This study would analyze these properties in our busy, urban emergency
department setting where time and safety of intravenous access are most critical.